Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06043102 · ClinicalTrials.gov registry record · NA
Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne
A NA study of Acne, sponsored by Ablon Skin Institute Research Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06043102 is a NA study of Acne that has completed, run by Ablon Skin Institute Research Center. The registered enrollment target is 30 participants, below the 141-participant average among 26 other Acne trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06043102, a NA study of Acne, has completed, sponsored by Ablon Skin Institute Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to further substantiate the effectiveness and safety of TheraClearX as a stand-alone treatment of mild to moderate acne in healthy teenagers and adults ages 12-40 over the course of 7 weeks. Participants will be asked to have TheraClearX treatments weekly for 6 sessions, attend a follow up appointment 2 weeks after the 6th session, have photos taken of their face and answer questionnaires related to their acne.
Conditions Studied
Interventions
- DEVICE TheraClearX
Study Locations (1)
California
- Ablon Skin Institute & Research Center - Manhattan Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-16 |
| Est. Completion | 2023-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06043102
The ClinicalTrials.gov registry entry for NCT06043102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 26 other Acne trials with a reported enrollment target (79% lower). The listed sponsor is Ablon Skin Institute Research Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne appearing as the primary indexed condition, and to 1 intervention - of which TheraClearX is the first listed.
NCT06043102 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06043102 about?
NCT06043102 is a clinical study titled "Study Evaluating the Efficacy and Safety of TheraClearX on Mitigating Mild to Moderate Acne". The goal of this clinical trial is to further substantiate the effectiveness and safety of TheraClearX as a stand-alone treatment of mild to moderate acne in healthy teenagers and adults ages 12-40 over the course of 7 weeks. Participants will be asked to have TheraClearX treatments weekly for 6 ses...
What is the current status of trial NCT06043102?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-05-16. Estimated completion is 2023-09-18.
What conditions does trial NCT06043102 study?
This clinical trial studies the following conditions: Acne.
What interventions are being tested in trial NCT06043102?
The interventions under investigation include: TheraClearX (DEVICE).
Who is sponsoring clinical trial NCT06043102?
This trial is sponsored by Ablon Skin Institute Research Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06043102 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
ACTIVE NOT RECRUITING · NA
-
The Effects of Cetyl Tranexamate Mesylate on the Appearance of Acne-Related Hyperpigmentation
COMPLETED · NA
-
An Exploratory Investigation of a Male Focused Skincare Supplement
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.